Her2-BATS and Pembrolizumab in Metastatic Breast Cancer
Clinical trial NCT03272334 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03272334
- Sponsor
- University of Virginia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-29
- Primary completion
- 2024-11-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.